EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells

J Natalie Howard, Callie Levinger, Selase Deletsu, Rémi Fromentin, Nicolas Chomont, Alberto Bosque iD, AIDS Clinical Trials Group (ACTG) A5325 Team

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von J Natalie Howard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington DC, United States of America. Hauptthemen laut MEDLINE: Isotretinoin, CD4-Positive T-Lymphocytes, Virus Latency, HIV Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Office of AIDS Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Development of novel therapeutic strategies that reactivate latent HIV and sensitize reactivated cells to apoptosis is crucial towards elimination of the latent viral reservoir. Among the clinically relevant latency reversing agents (LRA) under investigation, the γ c-cytokine IL-15 and the superagonist N-803 have been shown to reactivate latent HIV ex vivo and in vivo . However, their clinical benefit can be hindered by IL-15 promoting survival of infected cells. We previously identified a small molecule, HODHBt, that sensitizes latently infected cells to death upon reactivation with γ c-cytokines through a STAT-dependent pathway. In here, we aimed to identify and evaluate FDA-approved compounds that could also sensitize HIV-infected cells to apoptosis. Using the Connectivity Map (CMap), we identified the retinol derivative 13- cis -retinoic acid (Isotretinoin) causes similar transcriptional changes as HODHBt. Isotretinoin enhances IL-15-mediated latency reversal without inducing proliferation of memory CD4 T cells. Ex vivo analysis of PBMCs from ACTG A5325, where Isotretinoin was administered to ART-suppressed people with HIV, showed that Isotretinoin treatment enhances IL-15-mediated latency reversal. Furthermore, we showed that a combination of IL-15 with Isotretinoin promotes the reduction of translation-competent reservoirs ex vivo . Mechanistically, combination of IL-15 and Isotretinoin increases caspase-3 activation specifically in HIV-infected cells but not uninfected cells. Our results suggest that Isotretinoin can be a novel approach to target and eliminate translation-competent HIV reservoirs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsotretinoinCD4-Positive T-LymphocytesVirus LatencyHIV InfectionsHIV-1HumansInterleukin-15ApoptosisVirus Activation

Substanzen

IsotretinoinInterleukin-15

Autor:innen und Institutionen

  • Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington DC, United States of America.
  • Centre de recherche du CHUM et Département de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, Canada.

ORCID-Profile: Alberto Bosque

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Office of AIDS Research

Zitieren

APA

Howard, J. N., Levinger, C., Deletsu, S., Fromentin, R., Chomont, N., Bosque, A., & AIDS Clinical Trials Group (ACTG) A5325 Team (2024). Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012601

Vancouver

Howard JN, Levinger C, Deletsu S, Fromentin R, Chomont N, Bosque A, et al. Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012601

BibTeX
@article{Howard2024,
  author = {Howard, J Natalie and Levinger, Callie and Deletsu, Selase and Fromentin, Rémi and Chomont, Nicolas and Bosque, Alberto and AIDS Clinical Trials Group (ACTG) A5325 Team, AIDS Clinical Trials Group (ACTG) A5325 Team},
  title = {Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012601}
}
Kostenlos starten →